Michael F. Huang - Apr 22, 2024 Form 3 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Sr. VP of Clinical Development
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Apr 22, 2024
Transactions value $
$0
Form type
3
Date filed
4/30/2024, 05:53 PM
Next filing
Jul 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SLNO Employee stock option (right to buy) Apr 22, 2024 Common Stock 120K $21.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option shall vest on November 1, 2024 and one-forty-eighth of the shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.

Remarks:

Exhibit 24 - Power of Attorney